A YONDELIS® (trabectedin) Study in Advanced Relapsed Ovarian Cancer

• Research type

  Research Study

• Full title

  A Randomized, Open-Label Study Comparing the Combination of YONDELIS® and DOXIL®/CAELYX® With DOXIL®/CAELYX® Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

• IRAS ID

  129257

• Contact name

  Nicholas (Nick) Reed

• Contact email

  nick.reed@ggc.scot.nhs.uk

• Sponsor organisation

  Janssen Research & Development, LLC

• Eudract number

  2012-004808-34

• Clinicaltrials.gov Identifier

  NCT01846611

• REC name

  West of Scotland REC 1

• REC reference

  13/WS/0142

• Date of REC Opinion

  11 Jul 2013

• REC opinion

  Further Information Favourable Opinion